Trial Profile

Randomised, double-blind, multi-centre, placebo-controlled study to evaluate the efficacy of 6-day additional oral moxifloxacin administration 400 mg once a day (qd) after common antibiotic treatment on acute bacterial exacerbation of chronic obstructive pulmonary disease patients.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 07 Jul 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

02 Jul 2012 Actual end date (Jul 2012) added as reported by ISRCTN: Current Controlled Trials.
02 Jul 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
22 Jun 2010 Planned end date changed from Jul 2010 to Jul 2012 as reported by ISRCTN: Current Controlled Trials record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com